{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:33:38Z","timestamp":1768808018985,"version":"3.49.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ccm.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T01:15:21Z","timestamp":1690334121000},"page":"829-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host"],"prefix":"10.1016","volume":"44","author":[{"given":"Cara D.","family":"Varley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber C.","family":"Streifel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Bair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of Nontuberculous mycobacterial pulmonary disease: an Official ATS\/ERS\/ESCMID\/IDSA clinical practice fuideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Inf Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid1510.090196","article-title":"Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005","volume":"15","author":"Billinger","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3201\/eid1403.061143","article-title":"Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City","volume":"14","author":"Bodle","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.007_bib6","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1086\/648443","article-title":"Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology","volume":"49","author":"Cassidy","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1513\/AnnalsATS.201412-559OC","article-title":"Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012","volume":"12","author":"Henkle","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.rmed.2018.10.022","article-title":"Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population","volume":"145","author":"Marras","year":"2018","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib9","first-page":"1007","article-title":"The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey","volume":"135","author":"O'Brien","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid2206.151642","article-title":"Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009-2014","volume":"22","author":"Ringshausen","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"106164","DOI":"10.1016\/j.rmed.2020.106164","article-title":"Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation","volume":"173","author":"Schildkraut","year":"2020","journal-title":"Respir Med"},{"issue":"Suppl 58","key":"10.1016\/j.ccm.2023.06.007_bib16","first-page":"P1067","article-title":"Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: a NTM-NET collaborative study","volume":"44","author":"Wagner","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"139796","DOI":"10.1016\/j.scitotenv.2020.139796","article-title":"Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001\u20132016","volume":"740","author":"Thomson","year":"2020","journal-title":"Sci Total Environ"},{"issue":"1256","key":"10.1016\/j.ccm.2023.06.007_bib18","first-page":"50","article-title":"Incidence of nontuberculous mycobacterial disease in New Zealand, 2004","volume":"120","author":"Freeman","year":"2007","journal-title":"NZMJ"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3201\/eid2303.161927","article-title":"Pulmonary nontuberculous mycobacteria\u2013associated deaths, Ontario, Canada, 2001\u20132013","volume":"23","author":"Marras","year":"2017","journal-title":"Emerging Infectious Disease journal"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib20","first-page":"1112","article-title":"Mortality after respiratory isolation of nontuberculous mycobacteria. A Comparison of patients who did and did not meet disease criteria","volume":"14","author":"Novosad","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1513\/AnnalsATS.201606-474BC","article-title":"Deaths related to nontuberculous mycobacterial infections in the United States, 1999\u20132014","volume":"13","author":"Vinnard","year":"2016","journal-title":"Annals of the American Thoracic Society"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3201\/eid1509.081259","article-title":"Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons","volume":"15","author":"Piersimoni","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3201\/eid2703.201087","article-title":"Extrapulmonary nontuberculous mycobacteria infections in hospitalized patients, United States, 2009-2014","volume":"27","author":"Ricotta","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"31","key":"10.1016\/j.ccm.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.15585\/mmwr.mm6731a3","article-title":"Extrapulmonary nontuberculous mycobacterial disease surveillance - Oregon, 2014-2016","volume":"67","author":"Shih","year":"2018","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mayocp.2012.06.029","article-title":"Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study","volume":"88","author":"Wentworth","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(04)01130-2","article-title":"Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy","volume":"4","author":"Karakousis","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3201\/eid2303.161708","article-title":"Disseminated nontuberculous mycobacteria in HIV-infected patients, Oregon, USA, 2007-2012","volume":"23","author":"Varley","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/514014","article-title":"Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation","volume":"176","author":"Gordin","year":"1997","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.ccm.2023.06.007_bib29","unstructured":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV: National Institutes of Health CfDCaP, HIV Medicine Association, and Infectious Diseases Society of America. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. 2019 12\/16\/2022. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection."},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","article-title":"Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up","volume":"41","author":"Phillips","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-133-7-200010030-00008","article-title":"Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team","volume":"133","author":"Currier","year":"2000","journal-title":"Annals of internal medicine"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/315734","article-title":"Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds","volume":"182","author":"Dworkin","year":"2000","journal-title":"The Journal of infectious diseases"},{"issue":"15","key":"10.1016\/j.ccm.2023.06.007_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJM200004133421503","article-title":"Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"342","author":"El-Sadr","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM199608083350604","article-title":"Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group","volume":"335","author":"Havlir","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A\u00a0randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome","volume":"335","author":"Pierce","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/apc.2013.0270","article-title":"Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells\/muL who are virologically suppressed on cART?","volume":"28","author":"Yangco","year":"2014","journal-title":"AIDS patient care and STDs"},{"key":"10.1016\/j.ccm.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"8168750","DOI":"10.1155\/2022\/8168750","article-title":"Nontuberculous mycobacterial resistance to antibiotics and Disinfectants: Challenges Still Ahead","volume":"2022","author":"Tarashi","year":"2022","journal-title":"BioMed Res Int"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/433187","article-title":"Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients","volume":"41","author":"Gardner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2016.04.001","article-title":"Non-tuberculous mycobacterial infections in solid organ transplant recipients: an update","volume":"4","author":"Abad","year":"2016","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MOT.0000000000000665","article-title":"Nontuberculous mycobacteria in solid organ transplant","volume":"24","author":"Anjan","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/TP.0000000000001123","article-title":"Epidemiology and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients at a Midwestern center","volume":"100","author":"George","year":"2016","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11908-014-0421-1","article-title":"Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients","volume":"16","author":"Knoll","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ccm.2017.07.011","article-title":"Mycobacterial infections in solid organ and hematopoietic stem cell transplantation","volume":"38","author":"Pena","year":"2017","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/tri.12752","article-title":"Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients","volume":"29","author":"Yoo","year":"2016","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib45","doi-asserted-by":"crossref","first-page":"e13588","DOI":"10.1111\/ctr.13588","article-title":"Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Longworth","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tid.12170","article-title":"Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study.2014","volume":"16","author":"Longworth","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac608","article-title":"Risk factors for nontuberculous mycobacteria infections in solid organ transplant recipients: a multinational case-control study","volume":"76","author":"Mejia-Chew","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmi.2014.07.001","article-title":"Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis","volume":"21","author":"Longworth","year":"2015","journal-title":"Clin Microbiol Infection"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib49","doi-asserted-by":"crossref","first-page":"e13229","DOI":"10.1111\/tid.13229","article-title":"Non-tuberculous mycobacteria in lung transplant recipients: prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction","volume":"22","author":"Friedman","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.healun.2022.10.004","article-title":"Risk factors and outcomes of non-tuberculous mycobacteria infection in lung transplant recipients: a systematic review and meta-analysis","volume":"42","author":"Marty","year":"2023","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbmt.2017.09.015","article-title":"Incidence and risk factors for nontuberculous mycobacterial infection after allogeneic hematopoietic cell transplantation","volume":"24","author":"Beswick","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib52","doi-asserted-by":"crossref","first-page":"05","DOI":"10.1183\/13993003.02330-2017","article-title":"Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant","volume":"51","author":"Hirama","year":"2018","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib53","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41409-021-01239-4","article-title":"Outbreak of non-tuberculous mycobacteria in a paediatric bone marrow transplant unit associated with water contamination of needle-free connectors and literature review","volume":"56","author":"Habermann","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib54","doi-asserted-by":"crossref","first-page":"e13994","DOI":"10.1111\/petr.13994","article-title":"Low CD4 count may be a risk factor for non-tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients","volume":"25","author":"Wobma","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib55","first-page":"15","article-title":"Disseminated atypical mycobacterial infection in an allogeneic stem cell transplant recipient","volume":"27","author":"Karri","year":"2021","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ajd.12269","article-title":"Cutaneous non-tuberculous mycobacterial infection in patients with chronic graft-versus-host disease: a case series","volume":"56","author":"Moreno-Bonilla","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib57","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1017\/ice.2017.73","article-title":"Management of risks from water and ice from ice machines for the Very immunocompromised host: a Process Improvement Project Prompted by an Outbreak of rapidly growing mycobacteria on a pediatric hematopoietic stem cell transplant (Hsct) Unit","volume":"38","author":"Guspiel","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/INF.0000000000000391","article-title":"Rapidly growing mycobacteria among pediatric hematopoietic cell transplant patients traced to the hospital water supply","volume":"33","author":"Iroh Tam","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12185-015-1745-9","article-title":"Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients","volume":"101","author":"Kang","year":"2015","journal-title":"Int J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2023.06.007_bib60","first-page":"S134","article-title":"Nontuberculous mycobacterial infections in children with inborn errors of the immune system","volume":"68","author":"Haverkamp","year":"2014","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib61","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.chest.2021.05.046","article-title":"Pulmonary manifestations of GATA2 deficiency","volume":"160","author":"Marciano","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.06.007_bib62","doi-asserted-by":"crossref","first-page":"682934","DOI":"10.3389\/fimmu.2021.682934","article-title":"Case report: Hemophagocytic Lymphohistiocytosis and non-tuberculous Mycobacteriosis caused by a Novel GATA2 variant","volume":"12","author":"Mika","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.007_bib63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jfma.2011.11.004","article-title":"Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs)","volume":"110","author":"Lee","year":"2011","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib64","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00140007","article-title":"Susceptibility to nontuberculous mycobacterial lung disease","volume":"31","author":"Sexton","year":"2008","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib65","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12879-022-07656-0","article-title":"Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12879-019-4564-4","article-title":"Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-\u03b3 autoantibodies: a case report","volume":"19","author":"Yeh","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jiac.2020.09.031","article-title":"Subcutaneous injection of interferon gamma therapy could be useful for anti\u2013IFN-\u03b3 autoantibody associated disseminated nontuberculous mycobacterial infection","volume":"27","author":"Harada","year":"2021","journal-title":"J\u00a0Infect Chemother"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.31083\/j.fbl2704133","article-title":"Autoantibodies to tumor necrosis factor in patients with active pulmonary tuberculosis","volume":"27","author":"Kireev","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.007_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-Onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib71","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201205-0825OC","article-title":"Environment or host?","volume":"186","author":"Dirac","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1440-1843.2011.02076.x","article-title":"Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy","volume":"17","author":"Hojo","year":"2012","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib74","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1513\/AnnalsATS.201804-245OC","article-title":"Association between inhaled corticosteroid Use and pulmonary nontuberculous mycobacterial infection","volume":"15","author":"Liu","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib75","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.chest.2021.01.007","article-title":"Analysis of non-TB mycobacterial lung disease in patients with primary Sj\u00f6gren's syndrome at a Referral center","volume":"159","author":"Weingart","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib76","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib77","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1096\/fj.201701407R","article-title":"TNF-\u03b1-mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis","volume":"32","author":"Oh","year":"2018","journal-title":"Faseb j"},{"key":"10.1016\/j.ccm.2023.06.007_bib78","first-page":"1556","article-title":"Nontuberculosis mycobacteria infections and anti-tumor necrosis factor-alpha therapy","author":"KL","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","author":"Winthrop","year":"2013","journal-title":"Annals of the rheumatic diseases"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00408-013-9481-5","article-title":"Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea","volume":"191","author":"Lee","year":"2013","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib81","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00063514","article-title":"Mycobacterial diseases developed during anti-tumour necrosis factor-alpha therapy","volume":"44","author":"Yoo","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.06.007_bib82","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1038\/s41598-022-07968-w","article-title":"TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area","author":"Park","year":"2022","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib83","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2169\/internalmedicine.54.3956","article-title":"Mycobacterium abscessus pulmonary infection under treatment with tocilizumab","volume":"54","author":"Kobayashi","year":"2015","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.ccm.2023.06.007_bib84","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/cid\/ciu104","article-title":"Beyond tumor necrosis factor inhibition: the Expanding Pipeline of biologic therapies for inflammatory diseases and their associated infectious Sequelae","volume":"58","author":"Novosad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.007_bib85","first-page":"1505","article-title":"Mycobacterium abscessus infection during Ustekinumab treatment in Crohn's disease: a case report and review of the literature","volume":"12","author":"Shim","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13075-022-02842-6","article-title":"Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013\u20132018","volume":"24","author":"Jung","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.007_bib87","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1136\/ard.2011.151092","article-title":"Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients","volume":"70","author":"Koike","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib88","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/14740338.2020.1774550","article-title":"Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases","volume":"19","author":"Cantini","year":"2020","journal-title":"Expet Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.007_bib89","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ebiom.2015.07.014","article-title":"Efficacy of Adjunctive tofacitinib therapy in mouse models of tuberculosis","volume":"2","author":"Maiga","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001374","article-title":"Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research","volume":"6","author":"Kerschbaumer","year":"2020","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib91","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/annrheumdis-2019-216852","article-title":"Infections in baricitinib clinical trials for patients with active rheumatoid arthritis","volume":"79","author":"Winthrop","year":"2020","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"10.1016\/j.ccm.2023.06.007_bib92","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2015-207319","article-title":"Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis","volume":"75","author":"Winthrop","year":"2016","journal-title":"Annals of the rheumatic diseases"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib93","doi-asserted-by":"crossref","first-page":"e000866","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib94","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s40425-019-0717-7","article-title":"Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations","volume":"7","author":"Anastasopoulou","year":"2019","journal-title":"Journal for immunotherapy of cancer"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib95","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.1003304","article-title":"CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition","volume":"186","author":"Barber","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.ccm.2023.06.007_bib96","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jtho.2017.03.012","article-title":"Pericardial Tamponade caused by a Hypersensitivity response to tuberculosis reactivation after anti-PD-1 treatment in a patient with advanced pulmonary Adenocarcinoma","volume":"12","author":"Chu","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.ccm.2023.06.007_bib97","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jtho.2016.07.006","article-title":"Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis","volume":"11","author":"Fujita","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib98","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/0284186X.2015.1125017","article-title":"Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma","volume":"55","author":"Lee","year":"2016","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib99","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/1759-7714.13821","article-title":"Long-term remission of small cell lung cancer after reactivation of tuberculosis following immune-checkpoint blockade: a case report","volume":"12","author":"Sirgiovanni","year":"2021","journal-title":"Thoracic cancer"},{"issue":"9","key":"10.1016\/j.ccm.2023.06.007_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002960","article-title":"Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study","volume":"9","author":"Bae","year":"2021","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.ccm.2023.06.007_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.lungcan.2021.05.034","article-title":"Incidence of tuberculosis in advanced lung cancer patients treated with immune checkpoint inhibitors - a nationwide population-based cohort study","volume":"158","author":"Kim","year":"2021","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.ccm.2023.06.007_bib102","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.lungcan.2021.01.021","article-title":"Rapid development of pulmonary Mycobacterium avium infection during chemoradiotherapy followed by durvalumab treatment in a locally advanced NSCLC patient","volume":"153","author":"Baba","year":"2021","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib103","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.arbres.2021.04.014","article-title":"Cavitary Mycobacterium avium complex lung disease developed after Immunotherapy","volume":"58","author":"Chi","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib104","doi-asserted-by":"crossref","first-page":"067","DOI":"10.1093\/ofid\/ofaa067","article-title":"Development of Mycobacterium avium complex lung disease in patients with lung cancer on immune checkpoint inhibitors","volume":"7","author":"Fujita","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"21","key":"10.1016\/j.ccm.2023.06.007_bib105","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2169\/internalmedicine.6550-20","article-title":"Device-related Mycobacterium mageritense infection in a patient treated with nivolumab for Metastatic Breast cancer","volume":"60","author":"Koyama","year":"2021","journal-title":"Internal Medicine"},{"issue":"4","key":"10.1016\/j.ccm.2023.06.007_bib106","doi-asserted-by":"crossref","first-page":"00364","DOI":"10.1183\/23120541.00364-2022","article-title":"Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review","volume":"8","author":"Lombardi","year":"2022","journal-title":"ERJ Open Research"},{"issue":"2","key":"10.1016\/j.ccm.2023.06.007_bib107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/mco.2021.2470","article-title":"Mycobacterium avium complex lung disease in a patient treated with an immune checkpoint inhibitor: a case report","volume":"16","author":"Yamaba","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ccm.2023.06.007_bib108","doi-asserted-by":"crossref","first-page":"1047781","DOI":"10.3389\/fimmu.2022.1047781","article-title":"Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease","volume":"13","author":"Ratnatunga","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2023.06.007_bib109","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ajhp\/zxab389","article-title":"Outcomes of nontuberculous mycobacteria isolation among lung transplant recipients: a matched case-control with retrospective cohort study","volume":"79","author":"Grimes","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"10.1016\/j.ccm.2023.06.007_bib110","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/420746","article-title":"Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients","volume":"38","author":"Doucette","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib111","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3201\/eid1703.101164","article-title":"Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA","volume":"17","author":"Kendall","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ccm.2023.06.007_bib112","series-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","first-page":"3035","article-title":"Mycobacterium avium complex","author":"Luke","year":"2020"},{"issue":"1","key":"10.1016\/j.ccm.2023.06.007_bib113","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0029-2016","article-title":"The role of therapeutic drug monitoring in mycobacterial infections","volume":"5","author":"Peloquin","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"7","key":"10.1016\/j.ccm.2023.06.007_bib114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrrheum.2009.105","article-title":"Preventing and treating biologic-associated opportunistic infections","volume":"5","author":"Winthrop","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2023.06.007_bib115","doi-asserted-by":"crossref","first-page":"e0918","DOI":"10.1002\/rcr2.918","article-title":"Nontuberculous Mycobacterium-associated immune reconstitution inflammatory syndrome in a non-HIV immunosuppressed patient","volume":"10","author":"Kobayashi","year":"2022","journal-title":"Respirology Case Reports"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:17:07Z","timestamp":1759454227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0272523123000485"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.007","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}